US12195804B2

Treatment of squamous cell carcinoma

University of Texas System

Abstract

The present invention relates to a method of predicting the vulnerability of a squamous cell carcinoma (SCC) to inhibition by a PI3K inhibitor, preferably by a PI3K/mTOR inhibitor, including the selection of the patient predicted to benefit from therapeutic administration with the PI3K inhibitor, …

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Faye JOHNSON
Priority date: August 07, 2018
Filing date: February 13, 2020
Grant date: January 14, 2025
Publication date: January 14, 2025
Language: en
PDF source: https://patentimages.storage.googleapis.com/49/eb/af/ed9aad5644a1d7/US12195804.pdf
Metadata fetched: August 29, 2026 00:34